Abstract: A method of generating a device certificate. A method of generating a device certificate comprising, constructing a device certificate challenge at a device, sending information to a device certificate individualization server in response to the device certificate challenge, validating the device certificate challenge by the device certificate individualization server, and validating the device certificate response by the device.

Abstract: Metered data is accumulated and is indexed within a metering database of a client according to a metering ID (MID) and a content-associated ID (KID). The client selects a particular MID and metered data in the metering database having the selected MID, and constructs a challenge based on the selected metered data and sends same to a metering service. The metering service obtains the metered data from the challenge, stores same, and constructs a response. The client receives the response including a list of KIDs of the selected metered data in the challenge, and processes the list of KIDs by, for each KID in the list, deleting the metered data from the metering database having the selected MID and the KID.

Abstract: A request to render encrypted content is received and a chain of licenses corresponding to the content is located. The chain includes a leaf license linked to the content at one end of the chain, a root license at the other end of the chain, and any intermediate licenses therebetween. The leaf license and any intermediate licenses in the chain are each bound to the adjoining license in the chain toward the root license, and the root license is bound to an owner of a private key (PR-U). For each license in the chain, the license is verified and it is confirmed that the license allows the content to be rendered. A decryption key is obtained from the leaf license based on application of (PR-U) to the root license, the obtained key is applied to decrypt the encrypted content, and the decrypted content is rendered.

Abstract: A digital license includes an identification of a removal service that can authorize removing such license. A client selects the license to be removed and the service, constructs a challenge including therein a challenge license identification block (LIB) identifying the license to be removed, and sends the challenge to the service. The service receives the challenge, stores at least a portion of the challenge in a database, constructs a response corresponding to the challenge and including therein a response LIB identifying the license to be removed and an identification of the service, and sends the response to the client. The client receives the response, employs the response LIB from the response to identify the license to be removed, and removes the identified license upon confirming that the identification of the service in the identified license matches the identification of the service in the response.

Abstract: A high temperature blocking gel contains a blend of an aqueous fluid and carboxymethyl guar and a crosslinking agent. The gel exhibits excellent hydration capability in brines and positive viscosity generation and controls fluid loss from an oil well during drilling, completion and/or workover operations.

Abstract: A flip chip assembly machine (FCAM) (30) includes a main gantry (50) and a substrate camera gantry (40) that are configured to operate independently of each other and, respectively, support a die (12) and a substrate camera (38) for alignment purposes. The FCAM further includes a fluxer (130) for applying flux to the die. A flip-to-flux pick and place subassembly (116) picks up a die and places it in flux (46) independently of the operation of the main gantry, which may perform another task during the flux dwell time. A substrate carrier conveyor (154) includes a walking beam (260) to rapidly accelerate and decelerate substrate carrier movement into and out of the FCAM.

Abstract: A towline conveyor including both straight and curved sections employs self-lubricating non-metallic wearing blocks against which a metallic chain moves. The wearing blocks are made of a polymer matrix having additives to increase resistance to wear and abrasion, providing extended life relative to metal rollers. Preferably, the wearing blocks are molded replaceable inserts for carrier blocks mounted on the track of the conveyor.

Abstract: A mechanical gripper with a first clamp that can grab a workpiece in a first direction and a second clamp that grabs the workpiece in a second direction. The second direction is essentially perpendicular to the first direction so that the second clamp secures the workpiece onto the first clamp. Clamping in two different directions prevents relative movement of the workpiece within the gripper.

Abstract: The invention provides a compound of the formula: 1

Abstract: a gripper that can grasp an optical device. The gripper includes a jaw assembly coupled to a platform. The jaw assembly can be actuated by a fluid powered actuator to grasp a device. The fluid powered actuator may be a pneumatic cylinder. The actuator can be coupled to a pressure regulator that regulates the force exerted by the jaw assembly onto the device. The gripper may also have a speed regulator that regulates the speed of the jaw assembly. The jaw assembly may include a first jaw and a movable second jaw. The gripper jaws are coupled to the platform by fasteners in a manner that allows for interchangeability of the jaws.

Abstract: A novel method for the preparation of a compound of formula (I) from an N-protected-D-mannosamine. A compound of formula (I) is a useful intermediate for the preparation of kiftnensine, a potent and selective mannosidase inhibitor.

Abstract: A host securely transmits content to a peripheral thereof. The peripheral has a symmetric key (PK) and a copy of (PK) encrypted according to a public key (PU) of an entity ((PU(PK))). In the method, the host receives (PU(PK)) from the peripheral, and sends (PU(PK)) to the entity. The entity has a private key (PR) corresponding to (PU), applies (PR) to (PU(PK)) to obtain (PK), and sends (PK) back to the host. The host receives (PK) from the entity, encrypts at least a portion of the content according to (PK), and transmits the encrypted content to the peripheral. The peripheral may then decrypt the encrypted content based on (PK). A bind key (BK) encrypted by (PK) ((PK(BK))) may accompany (PU(PK)), where the content is to be encrypted according to (BK). Thus, (PK) is not revealed to the host.

Abstract: The present invention relates to benzofuran derivatives of formula (I) as shown below. ##STR1## The invention also relates to pharmaceutically acceptable salts and solvates of the derivatives of formula (I) as well as to processes for their preparation and to their use in the treatment of conditions mediated by tachykinins.

Abstract: The present invention relates to piperidine derivatives of formula (I) ##STR1## wherein R.sup.1 is a C.sub.1-4 alkoxy group; R.sup.2 is ##STR2## R.sup.3 is a hydrogen or halogen atom; R.sup.4 and R.sup.5 may each independently represent a hydrogen or halogen atom, or a C.sub.1-4 alkyl, C.sub.1-4 alkoxy or trifluoromethyl group;R.sup.6 is a hydrogen atom, a C.sub.1-4 alkyl, (CH.sub.2).sub.m cyclopropyl, --S(O).sub.n C.sub.1-4 alkyl, phenyl, NR.sup.7 R.sub.8, CH.sub.2 C(O)CF.sub.3 or trifluoromethyl group;R.sup.7 and R.sup.8 may each independently represent a hydrogen atom, or a C.sub.1-4 alkyl or acyl group;x represents zero or 1;n represents zero, 1 or 2;m represents zero or 1;and pharmaceutically acceptable salts and solvates thereof; to processes for their preparation; and their use in the treatment of conditions mediated by tachykinins.

Abstract: The present invention relates to piperidine derivatives of formula (I) ##STR1## wherein R.sup.1 is a C.sub.1-4 alkoxy group; R.sup.2 is ##STR2## R.sup.3 is a hydrogen or halogen atom; R.sup.4 and R.sup.5 may each independently represent a hydrogen or halogen atom, or aC.sub.1-4 alkyl, C.sub.1-4 alkoxy or trifluoromethyl group;R.sup.6 is a hydrogen atom, a C.sub.1-4 alkyl, (CH.sub.2).sub.m cyclopropyl, --S(O).sub.n C.sub.1-4 alkyl, phenyl,NR.sup.7 R.sup.8, CH.sub.2 C(O)CF.sub.3 or trifluoromethyl group;R.sup.7 and R.sup.8 may each independently represent a hydrogen atom, or a C.sub.1-4 alkyl or acyl group;x represents zero or 1;n represents zero, 1 or 2;m represents zero or 1;and pharmaceutically acceptable salts and solvates thereof; to processes for their preparation; and their use in the treatment of conditions mediated by tachykinins.

Abstract: Printing systems with a printing apparatus outputting plural regular print job set sheets in a process direction typically have a control system and an output system with a stacking tray in which the print job set sheets are stacked. The printing apparatus may also occasionally output, into the same stacking tray, purge sheets for removal, as determined by the control system. Here the output system includes process direction sheet offsetting apparatus controlled by the control system for automatically substantially offsetting the purge sheets in the process direction in the stacking tray relative to the regular print job set sheets, so that the purge sheets are readily visible and graspable for removal from the regular print job set sheets even from within a regular print job set, and are not stapled. The printing apparatus can thus continue to print and output more regular print job set sheets on top of the purge sheets.

Abstract: Compounds of formula (I) ##STR1## wherein X represents a hydrogen or chlorine atom, or a methyl group; and R represents a cycloalkyl or cycloalkenyl ring containing 5 to 8 carbon atoms, which ring is substituted by a hydroxy group, and is optionally substituted by a C.sub.1-6 alkyl group and salts and solvates thereof.The new compounds have been found to exhibit activities such as an anti-lipolytic action.Processes for preparing the compounds of formula (I) and compositions containing them are also described.

Abstract: Indole derivatives are disclosed of the general formula (I): ##STR1## wherein R.sub.1 is hydrogen, C.sub.1-6 alkyl or C.sub.3-6 alkenyl; R.sub.2 is a hydrogen, C.sub.1-3 alkyl, C.sub.3-6 alkenyl, phenyl, phen(C.sub.1-4)alkyl or C.sub.5-7 cycloalkyl; R.sub.3 and R.sub.4 are hydrogen, C.sub.1-3 alkyl or propenyl groups or together form an aralkylidene group; Alk is C.sub.2 -C.sub.3 alkylene chain and A is C.sub.2 -C.sub.5 alkylene chainand its physiologically acceptable salts and solvates.The compounds may be prepared, for example, by cyclization of a compound of general formula (II): ##STR2## where Q is the group NR.sub.3 R.sub.4 or a protected derivative thereof or a leaving group and R.sub.1 l, R.sub.2, R.sub.3, R.sub.4, A and Alk are as defined for formula (I).The compounds have a selective vosoconstrictor action and are useful in treating pain such as migraine. The compounds may be formulated as pharmaceutical compositions in conventional manner, preferably for oral administration.

Abstract: A cryogenic freezer apparatus for food products includes a conveyor within a thermally insulated enclosure. A cryogen injecting unit is located in said enclosure adjacent the opening thereof, and responsive to a cryogen control signal for introducing liquid cryogen in said enclosure. A blower unit in said enclosure directs cryogen vapor away from said enclosure opening toward the interior of said enclosure. The output of said blower unit being controllable by a blower control signal. A sensing unit within said enclosure senses the cooling capacity of the cryogen vapor at the enclosure opening and generates a sensor output signal which is indicative of the amount of cryogen vapor escaping out of said opening. A control unit, coupled to said sensing unit, said injecting unit, and to said blower unit generates a cryogen control signal and a blower control signal in response to the sensor output signal.

Abstract: Compounds are disclosed of formula (I): ##STR1## wherein one of R.sup.1, R.sup.2 and R.sup.3 represents hydrogen, C.sub.1-6 alkyl C.sub.3-6 alkenyl, hydroxy, C.sub.1-4 alkoxy or a C.sub.2-5 alkoxycarbonyl group, a phenyl or substituted phenyl group or a phen(C.sub.1-4)alkyl or substituted phen(C.sub.1-4)alkyl group; and the other two each independently represents hydrogen, C.sub.1-6 alkyl, or R.sup.2 and R.sup.3 together form an alkylene chain --(CH.sub.2).sub.n --where n is 2 or 3, bridging the nitrogen atoms to which they are attached; R.sup.4 and R.sup.5, each independently represents hydrogen, C.sub.1-3 alkyl or propenyl; R.sup.6 represents hydrogen, C.sub.1-3 alkyl, and the physiologically acceptable salts and solvates thereof.The compounds (I) have potent and selective vasoconstrictor activity and are potentially useful for the treatment of migraine. The compounds (I) may be formulated in conventional manner as pharmaceutical compositions for administration by any convenient route.